DMKJ
AVDL

David M. Knott Jr’s Avadel Pharmaceuticals AVDL Stock Holding History

David M. Knott Jr’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-363,000
Closed -$5.54M – 89
2025
Q3 		$5.54M Sell
363,000
-63,000
-15% -$820K 2.24% 10
2025
Q2 		$3.77M Hold
426,000
– – 1.71% 12
2025
Q1 		$3.34M Buy
426,000
+79,096
+23% +$662K 1.57% 14
2024
Q4 		$3.65M Buy
346,904
+14,904
+4% +$181K 1.32% 14
2024
Q3 		$4.35M Sell
332,000
-1,000
-0.3% -$15.2K 1.53% 16
2024
Q2 		$4.68M Hold
333,000
– – 1.87% 11
2024
Q1 		$5.62M Buy
333,000
+81,150
+32% +$1.21M 1.99% 14
2023
Q4 		$3.56M Buy
251,850
+30,000
+14% +$352K 1.36% 14
2023
Q3 		$2.29M Sell
221,850
-18,779
-8% -$252K 0.87% 21
2023
Q2 		$3.97M Sell
240,629
-50,484
-17% -$656K 1.58% 13
2023
Q1 		$2.67M Sell
291,113
-19,138
-6% -$157K 1.05% 20
2022
Q4 		$2.22M Sell
310,251
-80,610
-21% -$565K 0.84% 27
2022
Q3 		$1.96M Buy
390,861
+167,081
+75% +$920K 0.82% 26
2022
Q2 		$546K Buy
223,780
+16,117
+8% +$66.2K 0.23% 66
2022
Q1 		$1.42M Sell
207,663
-50,535
-20% -$347K 0.45% 51
2021
Q4 		$2.09M Buy
+258,198
New +$2.36M 0.71% 35

Other funds holding AVDL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GJL
Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

David M. Knott Jr's AVDL Position: Q4 2025 in Review

David M. Knott Jr sold out of Avadel Pharmaceuticals (AVDL) in Q4 2025, closing a stake of 363,000 shares — an estimated $5.54M sold.

David M. Knott Jr first reported a position in AVDL in Q4 2021 and held it in 16 quarters. The position peaked at $5.62M in Q1 2024. 207 funds tracked by Wall St. Rank hold AVDL as of Q4 2025.

  • David M. Knott Jr reported no remaining Avadel Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • David M. Knott Jr sold 363,000 Avadel Pharmaceuticals shares in Q4 2025, an estimated $5.54M.
  • David M. Knott Jr first reported a position in Avadel Pharmaceuticals in Q4 2021 and held it in 16 quarters.
  • David M. Knott Jr's Avadel Pharmaceuticals position peaked at $5.62M in Q1 2024.
  • 207 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2025.

Based on David M. Knott Jr's 13F filing for Q4 2025, filed 12 Feb 2026.